CERE
Cerevel Therapeutics Holdings Inc

3,251
Loading...
Loading...
Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Cerevel Therapeutics Holdings Inc?
What is the 52-week high for Cerevel Therapeutics Holdings Inc?
What is the 52-week low for Cerevel Therapeutics Holdings Inc?
What is Cerevel Therapeutics Holdings Inc stock price today?
What was Cerevel Therapeutics Holdings Inc stock price yesterday?
What is the PE ratio of Cerevel Therapeutics Holdings Inc?
What is the Price-to-Book ratio of Cerevel Therapeutics Holdings Inc?
What is the 50-day moving average of Cerevel Therapeutics Holdings Inc?

Latest CERE News

View

Advertisement. Remove ads.

Advertisement. Remove ads.